Huimei Xu

机构：Lanzhou University Second Hospital, First Affiliated Hospital of Jinan University, Lanzhou University · ORCID：0000-0002-1617-8407

发表论文 32 篇 · 总被引 278 次 · h-index 11

代表论文

• The efficacy of vonoprazan combined with different dose amoxicillin on eradication of Helicobacter pylori: an open, multicenter, randomized clinical study (2022 · Annals of Translational Medicine · 被引 43)
• CRISPR-cas technology: A key approach for SARS-CoV-2 detection (2023 · Frontiers in Bioengineering and Biotechnology · 被引 36)
• MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application (2024 · Pharmacological Research · 被引 27)
• Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis (2020 · European Journal of Gastroenterology & Hepatology · 被引 18)
• Antibiotics Resistance Prevalence of Helicobacter pylori Strains in Northwest China (2022 · Infection and Drug Resistance · 被引 17)
• Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease (2022 · European Journal of Pharmacology · 被引 16)